Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults: A Randomized Clinical Trial
Clinical Trial
[키워드] 95% CI
adverse event
Adverse reaction
age
aluminum
Analysis
Bahrain
Chinese
clinical
contributed
COVID-19
COVID-19 vaccines
Data collection
data set
dose
doses
double-blind
Effect
effective vaccine
Efficacy
efficacy analysis
Enrollment
evaluate
Evidence
Final
Follow-up
group
groups
had no
hydroxide
inactivated
Inactivated vaccine
injection
interim analysis
Intramuscular injection
laboratory-confirmed
median
men
occurred
Older
outcome
participant
per 1000 person-years
phase 3 trial
Primary outcome
randomization
Randomized
randomized clinical trial
reaction
receive
reduced
resulting
risk
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 vaccine
second dose
secondary outcome
Serious Adverse Event
Severe case
severe COVID-19
significantly
strain
symptomatic
the vaccine
Treatment
United Arab Emirate
Vaccine
vaccine dose
was collected
[DOI] 10.1001/jama.2021.8565 PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1001/jama.2021.8565 PMC 바로가기 [Article Type] Clinical Trial